Entrectinib in patients with ROS1 fusion-positive non-small cell lung cancer (NSCLC) or NTRK fusion-positive solid tumours: Analysis of response by line of therapy (vol 31, S472, 2020)

被引：0

作者：

Liu, S. V. ^{[1
]}

De Braud, F. ^{[2
]}

Drilon, A. ^{[3
]}

Doebele, R. C. ^{[4
]}

Patel, M. R. ^{[5
]}

Cho, B. C. ^{[6
]}

Ahn, M. J. ^{[7
]}

Chiu, C. H. ^{[8
]}

Farago, A. F. ^{[9
]}

Goto, K. ^{[10
]}

Lee, J. ^{[7
]}

Ohe, Y. ^{[11
]}

Ou, S. H. I. ^{[12
]}

Cassier, P. ^{[13
]}

Tan, D. S. W. ^{[14
]}

Otterson, G. A. ^{[15
,16
]}

Veronese, L. ^{[17
]}

Osborne, S. ^{[17
]}

Simmons, B. ^{[18
]}

Siena, S. ^{[19
,20
]}

机构：

[1] Georgetown Univ, Washington, DC 20057 USA

[2] Fdn IRCCS Ist Nazl Tumori, Dept Med Oncol & Hematol, Milan, Italy

[3] Mem Sloan Kettering Canc Ctr, Dept Med, Div Solid Tumor Oncol, Thorac Oncol Serv, 1275 York Ave, New York, NY 10021 USA

[4] Univ Colorado, Aurora, CO USA

[5] Univ Minnesota, Dept Med, Box 736 UMHC, Minneapolis, MN 55455 USA

[6] Yonsei Canc Ctr, Seoul, South Korea

[7] Sungkyunkwan Univ, Div Hematol Oncol, Samsung Med Ctr, Dept Med,Sch Med, Seoul, South Korea

[8] Taipei Vet Gen Hosp, Dept Chest Med, Taipei, Taiwan

[9] Massachusetts Gen Hosp, Boston, MA 02114 USA

[10] Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan

[11] Natl Canc Ctr, Tokyo, Japan

[12] Univ Calif Irvine, Sch Med, Irvine, CA 92717 USA

[13] Ctr Leon Berard, Dept Med Oncol, Lyon, France

[14] Natl Canc Ctr, Div Med Oncol, Singapore, Singapore

[15] Ohio State Univ, Ctr Comprehens Canc, Arthur G James Canc Hosp, Columbus, OH 43210 USA

[16] Ohio State Univ, Ctr Comprehens Canc, Richard J Solove Res Inst, Columbus, OH 43210 USA

[17] F Hoffmann La Roche Ltd, Basel, Switzerland

[18] Genentech Inc, San Francisco, CA 94080 USA

[19] Univ Milan, Dept Oncol & Hematooncol, Milan, Italy

[20] Metropolitano Niguarda, Niguarda Canc Ctr, Grande Osped, Milan, Italy

来源：

ANNALS OF ONCOLOGY | 2021年 / 32卷 / 04期

关键词：

D O I：

10.1016/j.annonc.2021.01.008

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：577 / 577

页数：1

共 1 条

[1] Entrectinib in patients with ROS1 fusion-positive non-small cell lung cancer (NSCLC) or NTRK fusion-positive solid tumours: of response by line of therapy
Liu, S. V.
De Braud, F.
Drilon, A.
Doebele, R. C.
Patel, M. R.
Cho, B. C.
Ahn, M-J.
Chiu, C-H.
Farago, A. F.
Goto, K.
Lee, J.
Ohe, Y.
Ou, S-H. I.
Cassier, P.
Tan, D. S. W.
Otterson, G. A.
Veronese, L.
Osborne, S.
Simmons, B.
Siena, S.
[J]. ANNALS OF ONCOLOGY, 2020, 31 : S472 - S473

← 1 →